Angiogenesis Inhibitors for Head and Neck Squamous Cell Carcinoma Treatment: Is There Still Hope?

BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) carries poor survival outcomes despite recent progress in cancer treatment in general. Angiogenesis is crucial for tumour survival and progression. Therefore, several agents targeting the pathways that mediate angiogenesis have been developed...

Descripción completa

Detalles Bibliográficos
Autores principales: Hyytiäinen, Aini, Wahbi, Wafa, Väyrynen, Otto, Saarilahti, Kauko, Karihtala, Peeter, Salo, Tuula, Al-Samadi, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236814/
https://www.ncbi.nlm.nih.gov/pubmed/34195084
http://dx.doi.org/10.3389/fonc.2021.683570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236814/
https://www.ncbi.nlm.nih.gov/pubmed/34195084
http://dx.doi.org/10.3389/fonc.2021.683570

Ejemplares similares